{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:30:41Z","timestamp":1777908641419,"version":"3.51.4"},"reference-count":32,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"published-print":{"date-parts":[[2018,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chelating agents such as diethylenetriamine pentaacetic acid (DTPA) can be used as a decorporation drug in the zinc (Zn) form to treat internal radioactive contamination after exposure to plutonium or americium in a nuclear accident. Although Zn-DTPA is normally administered intravenously, inhalation of Zn-DTPA in aerosol form is a better route for direct delivery to the lungs. This work investigates the feasibility of synthesizing Zn-DTPA from three common chemicals and aerosolizing it using a jet or ultrasonic nebulizer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      The particle size distribution (PSD) of this decorporation agent at different concentrations were tested\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      using two different methods: inertial impaction and aerodynamic time of flight. The particles were generated using either a jet nebulizer or an ultrasonic nebulizer. Two parameters, namely the mass median aerodynamic diameter and the geometric standard deviation, were assessed to determine the PSD of the generated aerosols. These parameters were obtained for different concentrations of Zn-DTPA using both nebulizers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and Conclusions:<\/jats:title>\n                    <jats:p>Zn-DTPA was successfully synthesized for decorporation purposes. Aerosol particles within the inhalable range were successfully generated by both nebulizers from four different concentrations of Zn-DTPA. It was found that the medication concentration did not affect the PSD of Zn-DTPA. The ultrasonic nebulizer was observed to produce a slightly larger aerosol particle size and required slightly longer treatment periods to deliver an effective dose to the lungs when compared with the jet nebulizer. Both nebulizers can be sustainably run to administer the agent for effective decorporation treatment of a large population after any major nuclear accident.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jamp.2017.1419","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T13:11:35Z","timestamp":1522329095000},"page":"311-320","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Aerosolization of Zn-DTPA Decorporation Agent Using Jet and Ultrasonic Nebulizers"],"prefix":"10.1177","volume":"31","author":[{"given":"Rym","family":"Mehri","sequence":"first","affiliation":[{"name":"Carleton University","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiquan","family":"Tang","sequence":"additional","affiliation":[{"name":"Carleton University","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar A.","family":"Matida","sequence":"additional","affiliation":[{"name":"Carleton University","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward P.C.","family":"Lai","sequence":"additional","affiliation":[{"name":"Carleton University","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"Nuclear Energy Insights: Comparing Fukushima and Chernobyl. 2015. https:\/\/www.nei.org\/master-document-folder\/backgrounders\/fact-sheets\/japan-comparing-chernobyl-and-fukushima Last viewed: 3\/7\/2017."},{"key":"e_1_3_3_3_2","first-page":"70","article-title":"Nuclear plants and natural disasters: Fukushima's fallout","volume":"56","author":"Sorkhabi RB","year":"2001","unstructured":"Sorkhabi RB: Nuclear plants and natural disasters: Fukushima's fallout. Earth. 2001; 56:70\u201371.","journal-title":"Earth"},{"key":"e_1_3_3_4_2","volume-title":"Modern Nuclear Chemistry","author":"Loveland WD","year":"2006","unstructured":"Loveland WD, , Morrissey DJ, , and Seaborg GT: Modern Nuclear Chemistry. John Wiley & Sons, New Jersey, NY; 2006."},{"key":"e_1_3_3_5_2","unstructured":"Food and Drug Administration: Highlights of Prescribing Information: Pentetate Zinc Trisodium (Zn-DTPA) for Intravenous Injection or Inhalation Administration 2004. https:\/\/www.fda.gov\/downloads\/drugs\/emergencypreparedness\/bioterrorismanddrugpreparedness\/ucm131639.pdf Last viewed: 2\/13\/2017."},{"key":"e_1_3_3_6_2","first-page":"195","volume-title":"Medical Toxicology","author":"Jones AL","year":"2004","unstructured":"Jones AL, , and Flanagan RJ: Diethylenetriaminepentaacete (DTPA). In: Dart RC. Medical Toxicology. Lippincott, Williams & Wilkins; Philadelphia, PA; pp 195\u2013196, 2004."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9046-x"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/096032719301200306"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/096032719501401108"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/rpd\/ncm299"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23932"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2006.11.027"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004032-198306001-00041"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/rpd\/ncm300"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/096032718500400603"},{"key":"e_1_3_3_16_2","first-page":"919","article-title":"Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA","volume":"46","author":"Stradling GN","year":"1984","unstructured":"Stradling GN, , Stather JW, , Sumner SA, , Strong JC, , Lennox AM, , and Ham SE: Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA. Health Phys. 1984; 46:919\u2013924.","journal-title":"Health Phys"},{"key":"e_1_3_3_17_2","unstructured":"Koizumi A Fukuda S Yamada Y Iida H and Shimo M: Dosage of DTPA administration by inhalation. International Congress of the International Radiation Protection Association Hiroshima Japan May 14\u201319 2000; No.P-3a-190 1\u20134."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2005.01.005"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(87)90258-X"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2016.1297"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2007.0643"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1586\/ers.11.89"},{"key":"e_1_3_3_23_2","volume-title":"The Mechanics of Inhaled Pharmaceutical Aerosols, An Introduction","author":"Finlay WH","year":"2001","unstructured":"Finlay WH: The Mechanics of Inhaled Pharmaceutical Aerosols, An Introduction. Academic Press, San Diego, CA; 2001."},{"key":"e_1_3_3_24_2","first-page":"33","article-title":"Spray-drying from fundamentals to pulmonary administration of therapeutic molecules","volume":"7","author":"Tsapis N","year":"2014","unstructured":"Tsapis N: Spray-drying from fundamentals to pulmonary administration of therapeutic molecules. Rev Farmacol Chile. 2014; 7:33\u201340.","journal-title":"Rev Farmacol Chile"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/10837450701366937"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-8502(98)00024-X"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.05501077"},{"key":"e_1_3_3_28_2","first-page":"260","article-title":"Study on reversed-phase high performance liquid chromatography separation condition and determination method of organic acids","volume":"19","author":"Zhao JC","year":"2001","unstructured":"Zhao JC, , Guo ZA, , Chang JH, , and Wang WJ: Study on reversed-phase high performance liquid chromatography separation condition and determination method of organic acids. Se Pu. 2001; 19:260\u2013263.","journal-title":"Se Pu"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.5740\/jaoacint.12-290"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17100140"},{"key":"e_1_3_3_31_2","volume-title":"Understanding Cascade Impaction and Its Importance for Inhaler Testing","author":"Copley M","year":"2007","unstructured":"Copley M: Understanding Cascade Impaction and Its Importance for Inhaler Testing. Manual, Copley Scientific; Nottingham; 2007."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1081\/DIS-120015376"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2009.0805"}],"container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jamp.2017.1419","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jamp.2017.1419","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jamp.2017.1419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:10:15Z","timestamp":1777644615000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jamp.2017.1419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10,1]]}},"alternative-id":["10.1089\/jamp.2017.1419"],"URL":"https:\/\/doi.org\/10.1089\/jamp.2017.1419","relation":{},"ISSN":["1941-2711","1941-2703"],"issn-type":[{"value":"1941-2711","type":"print"},{"value":"1941-2703","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]}}}